Status:
TERMINATED
Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
National Jewish Health
Conditions:
Idiopathic Interstitial Pneumonias
Eligibility:
All Genders
18+ years
Brief Summary
We hypothesize that a peripheral blood biomarker or biological signature (gene or protein expression pattern) of idiopathic interstitial pneumonias (IIPs) will simplify and improve the accuracy of dia...
Detailed Description
The Broad Challenge Area addressed in this proposal is (03) Biomarker Discovery and Validation, and the Specific Challenge Topic is 03-HL-101 (Identify and validate clinically relevant, quantifiable b...
Eligibility Criteria
Inclusion
- Sporadic cases of Idiopathic Pulmonary Fibrosis and other types of Idiopathic Interstitial Pneumonias.
- Family members ( with or without clinical disease) with a family history of pulmonary fibrosis.
Exclusion
- None.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
269 Patients enrolled
Trial Details
Trial ID
NCT01151527
Start Date
April 1 2010
End Date
February 1 2013
Last Update
September 9 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Jewish Health
Denver, Colorado, United States, 80206
2
Duke University Medical Center
Durham, North Carolina, United States, 27710